Eledon Pharmaceuticals Inc (NQ: ELDN )
1.849 -0.041 (-2.17%) Streaming Delayed Price Updated: 3:58 PM EDT, May 26, 2023 Add to My Watchlist
Headline News about Eledon Pharmaceuticals Inc
Recap: Eledon Pharma Q1 Earnings
May 11, 2023
Eledon Pharma's Earnings: A Preview
May 10, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Eledon Pharmaceuticals's Earnings: A Preview
March 29, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Eledon Pharmaceuticals (NASDAQ: ELDN) received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to evaluate tegoprubart for the treatment of...
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Eledon Pharmaceuticals (NASDAQ: ELDN) received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Tegoprubart for the Prevention of Allograft Rejection in...
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following